Karius Test

DIAGNOSTIC_TEST3 trials

Sponsors

Karius, Inc., Indiana University

Conditions

Acute Hematogenous OsteomyelitisFeverImmunocompromised HostMusculoskeletal InfectionNeutropeniaOsteomyelitisPneumonia CavitaryPneumonia Fungal

Unknown Phase

Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients

CompletedNCT03530072

Karius, Inc.Fever, Neutropenia

Start: 2018-05-07End: 2019-10-31Updated: 2023-02-10

Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections

CompletedNCT03846804

Indiana UniversityAcute Hematogenous Osteomyelitis, Musculoskeletal Infection, Osteomyelitis +2

Start: 2019-09-01End: 2022-06-02Updated: 2023-12-01

Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens

CompletedNCT04047719

Karius, Inc.Immunocompromised Host, Pneumonia, Bacterial, Pneumonia Cavitary +2

Start: 2019-11-05End: 2022-06-06Updated: 2023-02-09

Related Papers

P-2218. Evaluating the Timing of Bronchoscopy and Plasma Microbial Cell-Free DNA (mcfDNA) Sequencing on Diagnostic Yield: A Secondary Analysis of the Pneumonia in the ImmunoCompromised – use of the Karius Test for detection of Undiagnosed Pathogens (PICKUP) Study

Open Forum Infectious Diseases2025-01-29

Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study

Clinical Infectious Diseases2023-10-1051 citations